Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1157: Prognostic value of algorithmically-derived invasive hemodynamic indices of paravalvular regurgitation after TAVR with Self-Expanding Devices for heart failure rehospitalization and all-cause mortality – the APPOSE registry

Presenter: Geert Versteeg

October 27, 2025

Presentation TCT 2024

TCT 12: The Association Between Remnant Cholesterol and All-Cause Mortality and Cardiovascular Mortality Was Modified by Aged in American Adults: A Retrospective Cohort Study

Presenter: Rongchong Huang

October 29, 2024

Presentation TCT 2024

TCT 58: The Use of Intravascular Ultrasound During Percutaneous Coronary Intervention Does Not Reduce All-Cause In-Hospital Mortality but Doubles the Cost With Higher Utilization in Privately Insured Patients

Presenter: Mohammad Reza Movahed

October 29, 2024

Presentation TCT 2024

Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry

Presenter: Francesco Pelliccia

October 27, 2024

Presentation NY Valves 2024

Determinants of Intervention Type and All-Cause Mortality of TAVR and SAVR Patients Younger Than 75 Years in the Netherlands

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation THT 2024

Remote Management of Sitting Pulmonary Artery Pressures Tested Against a Performance Goal of Reduced HF Hospitalizations and All-cause Mortality in a Prospective Multi-Center Open Label PROACTIVE-HF Trial in NYHA Class III Heart Failure

Presenter: Liviu Klein

March 05, 2024

Presentation THT 2024

Relationship Between Remote, Ambulatory Pulmonary Artery Pressures and All-Cause Mortality in Patients with Chronic Heart Failure

Presenter: Michael R. Zile

March 05, 2024

Presentation TCT 2020

TCT 319: Risk Stratification of All-Cause Mortality Using Resistive Reserve Ratio in Patients With No Obstructive Coronary Artery Disease

Presenter: Takumi Toya

October 14, 2020

Presentation TCT Abstracts Posters 2018

A comparative study of one year all-cause mortality in ST Elevation myocardial infarction patients treated with prasugrel and ticagrelor after primary percutaneous coronary intervention

Presenter: Ayush Khurana

September 25, 2018

Presentation TCT 2018

All-Cause Mortality and Interpretation of Secondary Endpoints: The VEST and ODYSSEY Examples

Presenter: E. Magnus Ohman, Stuart J. Pocock

September 23, 2018

Presentation TCT 2016

TCT 318: Ten-year All-cause Mortality After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions in the Randomized Nordic Bifurcation Study

Presenter: Michael A. Kutcher, Issam D. Moussa

November 01, 2016

Presentation TCT 2016

TCT 487: Predictors of All-Cause Mortality in Sudden Cardiac Arrest Patients Referred for Cardiac Catheterization

Presenter: Michel R. Le May, Ivan C. Rokos

October 31, 2016

Presentation TCT 2015

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

Presenter: Jeffrey J. Popma, Mathew Williams, Nirat Beohar

October 13, 2015

Presentation TCT 2013

TCT-44. Impact of arterial access on all cause mortality in octogenarians, following Primary Percutaneous Intervention (PPCI) for ST elevation myocardial infarction (STEMI):...

Presenter: Albert Alahmar

October 29, 2013

Presentation

All-Cause Mortality Benefit of Revascularization vs. Medical Therapy in Patients Without Known CAD Undergoing Coronary CTA

Presenter: James K. Min

October 12, 2012

Presentation

CONFIRM Registry: Coronary CTA and Risk of All-Cause Mortality and Nonfatal MI in Subjects Without Chest Pain Syndrome

Presenter: I. Cho

June 15, 2012

Advertisement

TCT 1157: Prognostic value of algorithmically-derived invasive hemodynamic indices of paravalvular regurgitation after TAVR with Self-Expanding Devices for heart failure rehospitalization and all-cause mortality – the APPOSE registry

TCT 12: The Association Between Remnant Cholesterol and All-Cause Mortality and Cardiovascular Mortality Was Modified by Aged in American Adults: A Retrospective Cohort Study

TCT 58: The Use of Intravascular Ultrasound During Percutaneous Coronary Intervention Does Not Reduce All-Cause In-Hospital Mortality but Doubles the Cost With Higher Utilization in Privately Insured Patients

Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry

Determinants of Intervention Type and All-Cause Mortality of TAVR and SAVR Patients Younger Than 75 Years in the Netherlands

Remote Management of Sitting Pulmonary Artery Pressures Tested Against a Performance Goal of Reduced HF Hospitalizations and All-cause Mortality in a Prospective Multi-Center Open Label PROACTIVE-HF Trial in NYHA Class III Heart Failure

Relationship Between Remote, Ambulatory Pulmonary Artery Pressures and All-Cause Mortality in Patients with Chronic Heart Failure

TCT 319: Risk Stratification of All-Cause Mortality Using Resistive Reserve Ratio in Patients With No Obstructive Coronary Artery Disease

A comparative study of one year all-cause mortality in ST Elevation myocardial infarction patients treated with prasugrel and ticagrelor after primary percutaneous coronary intervention

All-Cause Mortality and Interpretation of Secondary Endpoints: The VEST and ODYSSEY Examples

TCT 318: Ten-year All-cause Mortality After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions in the Randomized Nordic Bifurcation Study

TCT 487: Predictors of All-Cause Mortality in Sudden Cardiac Arrest Patients Referred for Cardiac Catheterization

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

TCT-44. Impact of arterial access on all cause mortality in octogenarians, following Primary Percutaneous Intervention (PPCI) for ST elevation myocardial infarction (STEMI):...

All-Cause Mortality Benefit of Revascularization vs. Medical Therapy in Patients Without Known CAD Undergoing Coronary CTA

CONFIRM Registry: Coronary CTA and Risk of All-Cause Mortality and Nonfatal MI in Subjects Without Chest Pain Syndrome

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content